THE DAY, IN CONTEXTPolaris InsightsAn AI-powered comprehensive news portal

POLARIS INSIGHTS

Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?

Choosing between Amgen (NASDAQ: AMGN) and Vertex Pharmaceuticals (NASDAQ: VRTX) requires balancing scale against high-margin specialization. Amgen operates as a global pharmaceutical titan with a massive portfolio spanning multiple therapeutic areas.

Read the full account of the story

More from the Markets desk

More from Markets · Back to Polaris Insights